ALS Association Commits $2 Million to Support Early-Stage Clinical Trials of Two Emerging ALS Therapies

This funding was awarded through the ALS Association's Hoffman ALS Clinical Trial Awards Program, which aims to accelerate the development of new ALS treatments ARLINGTON, Va., Dec. 4, 2025 ...
The Scientist

ALS Disturbs Sleep Prior to Symptom Onset

Humans and mice with a predisposition for ALS displayed altered sleep patterns before symptoms began, offering a potential novel diagnostic and treatment approach. The researchers started by ...
EurekAlert!

Key pathway leading to neurodegeneration in early stages of ALS identified

Pictured are nuclei of induced pluripotent stem cell (iPSC)-derived motor neurons stained for contrast. The nucleus on the left has been treated with DMSO (control) and appears mostly blue. The ...
Business Wire

Unlearn and APST Research Partner to Build High-Quality Dataset to Accelerate ALS Clinical Trials

SAN FRANCISCO--(BUSINESS WIRE)--Unlearn ®, a pioneering artificial intelligence company, today announced a groundbreaking partnership with German-based APST Research (APST), a leading platform for ALS ...
Medical News Today

What to know about bulbar onset ALS

Bulbar onset ALS is a type of amyotrophic lateral sclerosis (ALS) that occurs due to the loss of motor neurons in the bulbar region of the brainstem. This progressive condition affects speech, ...